Literature DB >> 10551552

Chronic lymphocytic leukemia.

N Kalil1, B D Cheson.   

Abstract

The diagnosis and management of chronic lymphocytic leukemia (CLL) is reviewed, including the basic aspects of epidemiology, molecular biology, and cytogenetics with clinical relevance. The importance of immunophenotype in the differential diagnosis of other lymphoproliferative disorders related to CLL, staging, prognostic factors, promising new drugs, and approaches is summarized.

Entities:  

Mesh：

Year:  1999        PMID： 10551552

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


  8 in total

Review 1.  Current and developing chemotherapy for CLL.

Authors:  Emili Montserrat
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

2.  The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

Authors:  Sotirios G Papageorgiou; Christos K Kontos; Vassiliki Pappa; Hellinida Thomadaki; Frida Kontsioti; John Dervenoulas; Efstathios Papageorgiou; Theofanis Economopoulos; Andreas Scorilas
Journal:  Oncologist       Date:  2011-07-07

3.  Relationship between progression-free survival and overall survival in chronic lymphocytic leukemia: a literature-based analysis.

Authors:  C Beauchemin; J B Johnston; M È Lapierre; F Aissa; J Lachaine
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

Review 4.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

5.  Evaluation of Prognostic Impact of Soluble CD14 in B-Chronic Lymphocytic Leukemia.

Authors:  Waiel Al-Kahiry; Homam Sharshira; Amal Ghanem; Maha El-Gammal; Irene Lewis Mikhael
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-16       Impact factor: 0.900

6.  Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter.

Authors:  Gregory Haskin; Mikhail Kogan
Journal:  Integr Med (Encinitas)       Date:  2018-02

Review 7.  Novel agents for chronic lymphocytic leukemia.

Authors:  Mei Wu; Akintunde Akinleye; Xiongpeng Zhu
Journal:  J Hematol Oncol       Date:  2013-05-16       Impact factor: 17.388

Review 8.  Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia.

Authors:  Felice Pepe; Veronica Balatti
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.